Stem cell therapy for autoimmune disease: Overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting

R. K. Burt*, R. Arnold, R. Emmons, Y. Oyama, A. Marmont

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Hematopoietic stem cell transplantation as a treatment for autoimmune disease began in 1996 and has subsequently spread worldwide. In Europe phase III trials have opened, while in America phase III trials are being designed and funded by the National Institutes of Health. On 6 June 2002, clinicians and scientists from around the world met at Snowbird, Utah to discuss the results and future directions of stem cell therapy for autoimmune diseases. What follows are general concepts from chairpersons of this meeting.

Original languageEnglish (US)
Pages (from-to)S3-S5
JournalBone Marrow Transplantation
Volume32
DOIs
StatePublished - Aug 2003

Keywords

  • Autoimmune disease
  • Stem cell transplantation
  • Tissue regeneration

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint Dive into the research topics of 'Stem cell therapy for autoimmune disease: Overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting'. Together they form a unique fingerprint.

Cite this